GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (BOM:532296) » Definitions » Dividends per Share

Glenmark Pharmaceuticals (BOM:532296) Dividends per Share : ₹2.50 (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals Dividends per Share?

Glenmark Pharmaceuticals's dividends per share for the three months ended in Mar. 2024 was ₹0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2.50. Its Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Glenmark Pharmaceuticals's Dividend Yield % is 0.21%.

Warning Sign:

Glenmark Pharmaceuticals Ltd stock dividend yield is close to 5-year low.

During the past 5 years, the average Dividends Per Share Growth Rate was 5.20% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Glenmark Pharmaceuticals was 71.00% per year. The lowest was -32.50% per year. And the median was 7.70% per year.

For more information regarding to dividend, please check our Dividend Page.


Glenmark Pharmaceuticals Dividends per Share Historical Data

The historical data trend for Glenmark Pharmaceuticals's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals Dividends per Share Chart

Glenmark Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 2.50 2.50 2.50 2.50

Glenmark Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.50 - -

Competitive Comparison of Glenmark Pharmaceuticals's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glenmark Pharmaceuticals's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Glenmark Pharmaceuticals's Dividend Yield % falls into.



Glenmark Pharmaceuticals Dividends per Share Calculation

Dividends paid to per common share.


Glenmark Pharmaceuticals  (BOM:532296) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Glenmark Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ -34.53
=N/A

During the past 13 years, the highest Dividend Payout Ratio of Glenmark Pharmaceuticals was 0.19. The lowest was 0.06. And the median was 0.08.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Glenmark Pharmaceuticals Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
INR 2.5000002023-09-182023-09-192023-10-03Cash DividendannuallyINR:INR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.


Glenmark Pharmaceuticals's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=2.5/1160.75
=0.22 %

Current Share Price is ₹1160.75.
Glenmark Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹2.5.

During the past 13 years, the highest Dividend Yield of Glenmark Pharmaceuticals was 1.00%. The lowest was 0.16%. And the median was 0.35%.

Warning Sign:

Glenmark Pharmaceuticals Ltd stock dividend yield is close to 5-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glenmark Pharmaceuticals Dividends per Share Related Terms

Thank you for viewing the detailed overview of Glenmark Pharmaceuticals's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Glenmark Pharmaceuticals (BOM:532296) Business Description

Traded in Other Exchanges
Address
Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai, IND, 400099
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.

Glenmark Pharmaceuticals (BOM:532296) Headlines

No Headlines